Sung is a partner in the Life Sciences Health Industry Group in the Washington D.C. office. Sung provides counsel to companies during both the pre-market and post-market phases of product life cycles. He guides companies in developing, distributing, and marketing FDA-regulated products and, when necessary, in responding to regulatory and administrative enforcement actions by federal and state agencies such as FDA, USDA, and state attorneys general offices. Sung understands the unique business landscape of FDA-regulated products, and provides practical advice that suits the needs of the client’s business.
Experience
Representative matters
Representative matters
Conducts due diligence on drug and medical device companies during acquisitions to identify, assess, and prepare solutions for risks associated with acquisitions.
Represents drug, medical device, food, and cosmetics companies during government investigations and responds to government inquiries.
Counsels clients on responding to and reducing the risk of FDA enforcement actions.
Conducts due diligence on drug and medical device companies during acquisitions to identify, assess, and prepare solutions for risks associated with acquisitions.
Represents drug, medical device, food, and cosmetics companies during government investigations and responds to government inquiries.
Counsels clients on responding to and reducing the risk of FDA enforcement actions.
Counsels clients regarding the legality and enforcement risk associated with marketing claims on food and beverage labels.
Reviews labels, labeling, and claims made for food, dietary supplements, OTC / Rx drugs, and medical devices, and represents companies during FDA enforcement actions for alleged labeling violations.
Assists clients with compliance obligations for low-acid canned foods and acidified foods.
Represents clients whose products are detained or refused by FDA during importation.
Represents clients with organic labeling obligations and related enforcement actions by agencies.
Counsels companies on regulatory pathways for receiving clearance or approval for new drug and medical devices.
Counsels clients on regulatory submissions to the National Association of the Boards of Pharmacy and on ongoing litigation between industry participants.
Counsels clients on regulatory requirements for operating 503B outsourcing facilities.
Represents clients in communicating with FDA and advocating for products whose regulatory status are unclear.
Recognitions
- Ranked in Chambers USA as "Up and Coming" for Nationwide Food & Beverages: Regulatory & Litigation, 2024-2025
- Ranked in Chambers USA as "Up and Coming" for District of Columbia Healthcare: Pharmaceutical/Medical Products Reg., 2025
Credentials
Education
Education
- The George Washington University Law School, 2014, J.D.
- University of Wisconsin - Madison, 2010, B.S., Biology
Professional admissions & qualifications
Professional admissions & qualifications
- Virginia
- Washington, D.C.
News
1 / 5
Insights
Events
1 / 13